Biden’s COVID ‘rebound’ after treatment with Paxlovid serves as a reminder that the antiviral can have that rare outcome
admin President Joe Biden tested positive for COVID-19 for a third straight day on Monday, in…
Read MorePFE
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
Moderna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for the…
Read MoreL.A. County dodges face-mask mandate as community transmission rates stabilize, and U.S. government orders 66 million doses of Moderna’s pending booster
Los Angeles County has dropped a plan for a universal indoor face-mask mandate as COVID…
Read MoreL.A. County dodges face-mask mandate as community transmission rates stabilize, and U.S. government orders 66 million doses of Moderna’s pending booster
Los Angeles County has dropped a plan for a universal indoor face-mask mandate as COVID…
Read MoreRetooled, omicron-specific COVID boosters expected in September: report
The Biden administration is tweaking its COVID booster plans, according to a new report, and…
Read MorePublic school districts facing decision over face mask wearing, as BA.5 creates high levels of community transmission
A growing number of public school districts across the U.S. are reinstating face-mask mandates, or…
Read MoreDow up 200 points, stocks hit 6-week highs as investors shrug off weak GDP number
U.S. stocks rallied to their highest level in more than six weeks Thursday as investors…
Read MoreU.S. stocks erase part of post-Fed rally after GDP report
U.S. stocks turned lower Thursday, erasing some of Wednesday’s spectacular post-Fed rally. How stocks are…
Read MorePublic school districts facing decision over face mask wearing, as BA.5 creates high levels of community transmission
A growing number of public school districts across the U.S. are reinstating face-mask mandates, or…
Read MorePfizer reports big profit and revenue beats, as COVID drug sales increase by nearly $9 billion
Shares of Pfizer Inc. PFE, -2.30% gained 0.3% in premarket trading Thursday, after the pharmaceutical…
Read More